On International Women's Day, Organon Canada is encouraging businesses to Invest in HER and help address gender inequities through women's health

"This program goes beyond internal resources and represents a transformative shift in most company's corporate cultures. All of our employees, including men, are critical to the success of this program, as it's the collective effort that will truly make the difference." says Amy Cairns, Vice President, Women's Health and Established Brands. "HER Professional Journey is a concrete action of Organon Canada to act as a proactive advocate to support women, and we are hoping to make it an industry standard."

Organon Canada believes that not only is investing in women's careers the right thing to do, but also that keeping women in the workplace is good for business. A 2018 study from the World Bank estimated that eliminating gender inequality in the workplace would add $160.2 trillion to the global economy.^iv Furthermore, organizations with more balanced representation have been shown to be more profitable, productive and innovative - with companies in the top quartile for gender diversity being 39% more likely to financially outperform its peers and competitors.ⁱⁱ

Organon Canada is also continuing to invest in a range of programs and grants that increase awareness of women's health to help close persistent care gaps in Canada. To support this work, the company is establishing new dedicated funding for unrestricted and independent grants that will focus on menopause education for healthcare professionals in Canada. More information will be announced at a later date about this educational program.

Organon Canada is encouraging other organizations to join in the movement and Invest In HER, so that women are supported throughout their career journeys. Visit https://www.organon.com/canada-en/her-professional-journey/ to find out more about our program and initiatives.

Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon offers more than 60 medicines and products in women's health in addition to a growing biosimilars business and a large franchise of established medicines across a range of therapeutic areas. Organon's existing products produce strong cash flows that support investments in innovation and future growth opportunities in women's health and biosimilars. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.

For more information, connect with us on LinkedIn.

SOURCE Organon Canada Inc.